Bile acid receptor 3D structures

1osh, 3fli, 3l1b – hFXR LBD + non-steroidal agonist - human

5q0i – hFXR LBD + PPAR gamma coactivator peptide

3fxv, 3gd2, 3okh, 3oki, 3olf, 3omk, 3omm, 1ot7 – hFXR LBD + CDC derivative + RPGR-interacting protein peptide

4oiv – hFXR LBD + antagonist

4wvd, 5q0w, 5q15, 5wzx, 5q0j, 5q0k, 5q0l, 5q0m, 5q0n, 5q0o, 5q0p, 5q0q, 5q0r, 5q0s, 5q0t, 5q0u, 5q0v, 5q0x, 5q0y, 5q0z, 5q10, 5q11, 5q12, 5q13, 5q14, 5q16, 5q17, 5q18, 5q19, 5q1a, 5q1b, 5q1c, 5q1d, 5q1e, 5q1f, 5q1g, 5q1h, 5q1i - hFXR LBD + NCOA1 peptide

3bej, 3dct, 3dcu, 3hc5, 3hc6, 3rut, 3ruu, 3rvf, 6itm – hFXR LBD + non-steroidal agonist + NCOA1 peptide

6a5w - hFXR LBD + thiazole derivative + NCOA1 peptide

6a5x - hFXR LBD (mutant) + thiazole derivative + NCOA1 peptide

5y44 – hFXR LBD + moderator + NCOA1 peptide

6a5y, 6a5z - hFXR LBD (mutant) + thiazole derivative + NCOA1 peptide + RXR-a + retinoic acid

6a60 - hFXR LBD (mutant) + isoxazole derivative + NCOA1 peptide + RXR-a + retinoic acid

3oof, 3ook, 3p88, 3p89 – hFXR LBD (mutant) + non-steroidal agonist + NCOA1 peptide

5iaw, 6hl0 - hFXR LBD + NCOA2 peptide

1osv – hFXR LBD + CDC derivative + NCOA2 peptide

5z12 - hFXR LBD (mutant) + indole derivative + NCOA2 peptide + RXR-a + retinoic acid

6hl1 – hFXR LBD + CDC + NCOA2 peptide

5ick – hFXR LBD + feroline + NCOA2 peptide

5y1j, 7d42, 7vue – hFXR LBD + drug + NCOA2 peptide

5y49 – hFXR LBD + moderator + NCOA2 peptide

5yxb, 5yxd, 5yxj, 5yxl – hFXR LBD + pyridine derivative + NCOA2 peptide

7trb – hFXR LBD + inhibitor + NCOA2 peptide

4qe8 – hFXR LBD + DM175 + NCOA2 peptide

8hbm - hFXR 127-227 + RXR-a